Steroid equivalency is an important concept for doctors to understand, as it helps inform decisions about the dosage of certain medications and the effects they may have on a patient. Steroid equivalency charts provide a useful guide to help doctors determine the equivalent dose of various steroids, as well as the relative potency of different steroids. This article will provide an overview of steroid equivalency, including a comprehensive charting guide.
Steroid equivalency is a concept used to compare the potency of different steroids. It is based on the idea that different steroids have different potencies, and therefore, different doses of different steroids are needed to achieve the same effect. For example, a doctor may prescribe a steroid with a potency of 1:10, meaning that one milligram of the steroid is equivalent to 10 milligrams of another steroid. This concept is used to determine the appropriate dosage of a particular steroid for a patient.
There are several different types of steroids, each with its own unique properties. Corticosteroids are the most commonly prescribed type of steroid, and they are used to treat a variety of conditions, such as asthma, eczema, and inflammatory arthritis. Anabolic steroids are another type of steroid, and they are used to increase muscle mass and strength. Androgenic steroids are used to treat conditions such as hypogonadism and delayed puberty.
The following chart provides a comprehensive guide to steroid equivalency. It shows the potency of various steroids relative to one another, as well as the equivalent dose of each steroid.
| Steroid | Potency (mg) | Equivalent Dose (mg) |
|---|---|---|
| Prednisone | 1:4 | 4 mg |
| Dexamethasone | 1:4 | 4 mg |
| Methylprednisolone | 1:5 | 5 mg |
| Hydrocortisone | 1:20 | 20 mg |
| Betamethasone | 1:25 | 25 mg |
| Triamcinolone | 1:30 | 30 mg |
There are several factors that can affect the potency of a steroid, and therefore, the equivalent dose of the steroid. These factors include the route of administration, the patient's age, weight, and medical history, and any other medications the patient is taking.
Steroid equivalency is an important concept for doctors to understand, as it helps inform decisions about the dosage of certain medications and the effects they may have on a patient. Steroid equivalency charts provide a useful guide to help doctors determine the equivalent dose of various steroids, as well as the relative potency of different steroids. By understanding the concept of steroid equivalency, doctors can ensure that their patients are receiving the appropriate dose of the medication and the desired effect.
1.
Major Shifts in Urothelial Cancer Care: Immunotherapy Redefines Standards
2.
Two medications might work better for breast cancers that are resistant to one.
3.
Living near St. Louis-area Coldwater Creek during childhood linked with higher risk of cancer from radiation
4.
Resection for Early Liver Cancer Tied to Improved Survival.
5.
Researchers publish action plan to address appendiceal cancer enigmas
1.
Management of Relapsed Synovial Sarcoma: Current Treatment Strategies and Emerging Therapies
2.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
3.
Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression
4.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
5.
The latest research on Thyroid Cancer: Symptoms, Diagnosis, and Treatment Options
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
2.
Efficient Management of First line ALK-rearranged NSCLC - Part III
3.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
4.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
5.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation